Navigation Links
Full Year 2008 Results Date Notification - 19 February 2008
Date:2/9/2009

PHILADELPHIA and DUBLIN, Ireland, February 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce full year 2008 earnings on Thursday 19 February 2009.

    Results press release will be issued at:    12:00 GMT / 07:00 EST
    Investor meeting and conference call time:  14:00 GMT / 09:00 EST

Investor & Analyst meeting and conference call:

Angus Russell, Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Gregoire, President, Human Genetic Therapies will host the investor and analyst meeting and conference call at 14:00 GMT/9:00 EST.

The meeting will take place at the offices of Deutsche Bank, Winchester House, 1 Great Winchester Street, London, EC2N 2DB.

Please email ssalah@shire.com to register to attend this meeting in London.

    The details of the conference call are as follows:

    UK and International dial in  +44(0)20-7806-1957
    US dial in:                      +1-718-354-1388
    Password/Conf ID:                        9465839

    Live Webcast:
http://www.shire.com/shire/InvestorRelations/quarterlyresults.jsp?tn=2&m1=48

Replay:

A replay of the presentation will be available for two weeks by phone and by webcast for one year. Details are as follows:

    UK and International dial in:      +44(0)20-7806-1970
    US dial in                            +1-718-354-1112
    Pin code                            
'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , August 4, 2015 ... Market Research, titled, "World Cardiac Biomarker - Market ... market would generate the revenue of $2,085.9 million ... 2015 to 2020. Cardiac Troponins (T, I) would ... period due to high sensitivity and specificity. ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... point-of-care (POC) diagnostic tests – today announced that Robert A. Gregg, PhD, has ... has more than 30 years of relevant experience and remarkable achievements in the ...
(Date:8/4/2015)... CAMBRIDGE, Mass. , Aug. 4, 2015  Blueprint ... and developing highly selective kinase drugs for genomically defined ... executive officer, will present a company overview at the ... 2015 at 1:20 p.m. EDT. A live ... the Investors section of the Blueprint Medicines website at ...
(Date:8/4/2015)... ... 04, 2015 , ... On August 4, 2015, the White House will host ... across the United States to talk about their experiences with innovation and present their ... be among the attendees. , One of the day’s aims is to grow the ...
Breaking Biology Technology:Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2
... ATLANTA, May 1 CryoLife, Inc., (NYSE: ... company, announced today,that Harvey Morgan has been elected ... Morgan is a Managing Director at Bentley,Associates L.P., ... more than 35 years of investment banking experience ...
... 1 /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin ... leading manufacturer and distributor in China of ... medical industry and,glucose and starch products for ... appointment of Ms. Melody Shi as its ...
... Therapeutics (Amex:,CXM) announced today that Richard A. Schatz, M.D., ... early pioneer of coronary stent,technology and is best known ... Palmaz-Schatz stent. Dr. Schatz is Research Director of,Cardiovascular Interventions ... in La Jolla, California. He is also active in ...
Cached Biology Technology:Harvey Morgan Joins CryoLife Board of Directors 2Shengtai Pharmaceutical, Inc. Appoints New CFO 2Shengtai Pharmaceutical, Inc. Appoints New CFO 3Richard A. Schatz, M.D. Joins Cardium's Scientific Advisory Board 2Richard A. Schatz, M.D. Joins Cardium's Scientific Advisory Board 3Richard A. Schatz, M.D. Joins Cardium's Scientific Advisory Board 4
(Date:7/21/2015)... July 21, 2015 Today, ZTE announced its ... as well as expected revenues in 2015 that relate to sales ... revenue guidance of approximately 2,200 MSEK for 2015. Jörgen ... leading smartphone manufacturer in China and we ... 02 5 for Axon , ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/8/2015)... , July 8, 2015 Summary ... and the fourth most fatal, with a mortality rate ... poor prognosis of pancreatic cancer patients has highlighted a ... which is not being met by the current market. ... array of products with varying molecule types and mechanisms ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... York City/Great Neck, NY) The Brain & Behavior ... Research on Schizophrenia and Depression) has announced approximately $4 ... has invested close to $300 million in research to ... for mental illness. From about 500 applicants, forty ...
... pathogen that causes Lyme Diseaseunlike any other known organismcan ... needs to make proteins and enzymes. Instead of iron, ... thus eluding immune system defenses that protect the body ... Borrelia burgdorferi requires unusually high levels of ...
... researchers have taken an important step in the ongoing battle ... a breakthrough device that can immediately detect the presence of ... lighter than a cellphone and about the size of a ... measure nicotine in the air. A sensor chip then records ...
Cached Biology News:Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 2Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 3Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 4Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 5Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 6Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 7Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 8Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 9Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 10Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 11Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants 12Scientists reveal quirky feature of Lyme disease bacteria 2Scientists reveal quirky feature of Lyme disease bacteria 3Scientists create new tools for battling secondhand smoke 2Scientists create new tools for battling secondhand smoke 3
Incomplete Adjuvant...
The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
HiTrap Streptavidin HP, 5 x 1 ml. Category: Chromatography Systems & Accessories, Systems....
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
Biology Products: